Recently, multiple studies have reported that Plk1 is a potential therapeutic target for eliminating tumor-initiating cells in various tumor types [28-32], implying that inhibiting Plk1 could be useful for combating relapse and metastasis of tumors. The gene discussed is PLK1; the disease is neoplasm.